Dr. Kim Eagle provides a weekly tip for clinicians on the front lines of the COVID-19 pandemic. This week's tip focuses on the WHO Solidarity trial and whether COVID-19 drugs (i.e., remdesivir, hydroxychloroquine, lopinavir and interferon) demonstrated a mortality benefit among patients with COVID-19.

Clinical Topics: COVID-19 Hub, Novel Agents, Statins

Keywords: EaglesEyeView, ACC COVID-19 Podcast, COVID-19, Coronavirus, Coronavirus Infections, severe acute respiratory syndrome coronavirus 2, remdesivir, Hydroxychloroquine, Lopinavir

< Back to Listings